•
Jun 29, 2024

Masimo Q2 2024 Earnings Report

Masimo's Q2 2024 financial performance was reported, featuring revenue contributions from both healthcare and non-healthcare segments and an increase in full-year guidance.

Key Takeaways

Masimo reported consolidated revenue of $496.3 million for Q2 2024, with healthcare revenue at $343.9 million and non-healthcare revenue at $152.4 million. GAAP net income per diluted share was $0.29, and non-GAAP net income per diluted share was $0.86. The company increased its full-year 2024 guidance for healthcare revenue, consolidated operating income, and consolidated EPS.

Consolidated revenue reached $496.3 million.

Healthcare revenue amounted to $343.9 million.

Non-healthcare revenue totaled $152.4 million.

GAAP net income per diluted share was $0.29.

Total Revenue
$496M
Previous year: $455M
+9.0%
EPS
$0.86
Previous year: $0.62
+38.7%
Gross Profit
$255M
Previous year: $221M
+15.2%
Cash and Equivalents
$130M
Previous year: $151M
-14.0%
Free Cash Flow
$66.9M
Previous year: $11.7M
+471.8%
Total Assets
$2.89B
Previous year: $3.01B
-3.9%

Masimo

Masimo

Forward Guidance

Masimo provided estimates for its third quarter 2024 and updated full-year 2024 guidance.